Glenmark Pharmaceuticals was founded with a vision to emerge as a leading integrated research-based, global pharmaceutical company. Their branded generics business has a significant presence in markets across emerging economies including India.
The generics business services the requirements of developed markets such as US and Western Europe. The company sells products in over 65 countries, including the US, various countries in the EU, South America, and India.
With 14 manufacturing and three research and development centres dedicated to the goal of enriching lives across the globe and employees from across 60 nationalities, the company is committed to creating ‘a new way for a new world’.